Rare Neurological Disease Treatment Market Scope And Analysis

  • Report Code : TIPRE00008485
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Rare Neurological Disease Treatment Market Analysis by 2031

Buy Now

Rare Neurological Disease Treatment Market Report Rare Neurological Disease Treatment Market Size and Share Rare Neurological Disease Treatment Market Scope and Analysis

Rare Neurological Disease Treatment Market Report Scope

Report Attribute Details
Market size in 2021 US$ 7.6 Billion
Market Size by 2031 US$ 14.5 Billion
Global CAGR (2023 - 2031) 8.7%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Indication
  • Narcolepsy
  • Amyotrophic Lateral Sclerosis
  • Alzheimer's Disease
  • Multiple Sclerosis
  • Spinal Muscular Atrophy
  • Duchenne Muscular Dystrophy
By Drug Type
  • Organic Compounds
  • Biologics
By Mode of Administration
  • Oral
  • Injectable
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Allergan AbbVie Inc
  • Bayer AG
  • GlaxoSmithKline plc
  • Johnson Johnson Services Inc
  • Merck Co Inc
  • Novartis
  • Pfizer Inc
  • Sanofi
  • Teva Pharmaceutical Industries Ltd
  • Takeda Pharmaceutical